| Nov 15 |
Ocular Therapeutix Inc (OCUL) Q3 2024 Earnings Call Highlights: Strong Financial Position and ...
|
| Nov 14 |
Ocular Therapeutix, Inc. (OCUL) Q3 2024 Earnings Call Transcript
|
| Nov 14 |
Ocular Therapeutix (OCUL) Reports Q3 Loss, Lags Revenue Estimates
|
| Nov 14 |
Ocular Therapeutix: Q3 Earnings Snapshot
|
| Nov 14 |
Ocular Therapeutix GAAP EPS of -$0.22 beats by $0.02, revenue of $15.43M misses by $1.71M
|
| Nov 14 |
Ocular Therapeutix™ Reports Third Quarter 2024 Results and Business Highlights
|
| Nov 14 |
Earnings Scheduled For November 14, 2024
|
| Nov 13 |
Harrow (HROW) Reports Q3 Loss, Lags Revenue Estimates
|
| Nov 13 |
Ocular Therapeutix Q3 2024 Earnings Preview
|
| Nov 13 |
Ocular Therapeutix™ to Present at the Jefferies London Healthcare Conference and Ophthalmology Innovation Summit XIV
|
